A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Youchao,Xiao

第一单位： Department of Neurosurgery, First Hospital of Shanxi Medical University, Taiyuan, China.

作者： Youchao,Xiao ^[1] ; Gang,Cui ^[2] ; Xingguang,Ren ^[3] ; Jiaqi,Hao ^[1] ; Yu,Zhang ^[1] ; Xin,Yang ^[1] ; Zhuangzhuang,Wang ^[1] ; Xiaolin,Zhu ^[1] ; Huan,Wang ^[1] ; Chunyan,Hao ^[4] ; Hubin,Duan ^[1]

作者单位： Department of Neurosurgery, First Hospital of Shanxi Medical University, Taiyuan, China. ^[1] Department of Neurosurgery, The Third Affiliated Hospital of Shandong First Medical University (Affiliated Hospital of Shandong Academy of Medical Sciences), Jinan, China. ^[2] Department of Neurosurgery, General Hospital of TISCO, Taiyuan, China. ^[3] Department of Geriatrics, First Hospital of Shanxi Medical University, Taiyuan, China. ^[4] Department of Neurosurgery, Lvliang People's Hospital, Lvliang, China. ^[5]

关键词 biomarker cancer stem cell gene signature immune checkpoint isocitrate dehydrogenase mutation prognostic value

DOI 10.3389/fonc.2020.605737

PMID 33381460

发布时间 2021-01-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Frontiers in oncology

2020年10卷

605737页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除